Search - tctmd.com

Displaying 101 - 120 of 144

Sort: Relevancy | Date

Presentation THT 2024

The TMVR Landscape: Second Generation Devices and Clinical Trial Pathways

Presenter: Martin B. Leon

March 04, 2024

Presentation THT 2024

Reducing Congestion by Removing Fluid From the Interstitium

Presenter: William T. Abraham

March 04, 2024

Presentation THT 2024

Early Experience With Devices That Reduce Kidney Vascular Afterload From the Veins

Presenter: Ulrich P. Jorde

March 04, 2024

Presentation THT 2024

Early Experience With Devices That Increase Kidney Perfusion From the Aorta

Presenter: Jennifer A. Cowger

March 04, 2024

Presentation THT 2024

BrioHealth Solutions: Pump and Clinical Trial Design

Presenter: James Long

March 04, 2024

Presentation THT 2024

Biomarkers of Congestion: Utility in Clinical Practice and Clinical Trials

Presenter: James Januzzi

March 04, 2024

Presentation THT 2024

Mechanisms of Diuretic Resistance

Presenter: Jeffrey Testani

March 04, 2024

Presentation THT 2024

Contemporary Pharmacological Therapies for Acute Heart Failure

Presenter: Wilfried Mullens

March 04, 2024

News Features THT 2023

The Promise of AI for Improving Health Equity in Heart Failure

Todd Neale

April 04, 2023

News Conference News THT 2023

More Early Insights Into Interatrial Shunts in HF, but Little to Focus the Field

Shelley Wood

March 24, 2023

News Conference News THT 2023

High-Intensity Care After Acute HF Pays Off Across LVEF Spectrum: STRONG-HF

Todd Neale

March 23, 2023

News Conference News THT 2023

REDUCE LAP-HF II Subanalysis Makes the Case for Invasive Exercise Tests

Yael L. Maxwell

March 22, 2023

Presentation THT 2023

TMVR Clinical Trials: Ready for Prime Time or Stuck in the Mud?

Presenter: Martin Leon

March 22, 2023

News Conference News THT 2023

Pulmonary Artery Denervation Makes Inroads in PAH Due to Left-Sided HF

Shelley Wood

March 21, 2023

Presentation THT 2023

Engaging Patients and Clinicians With Remote Pulmonary Artery Pressures Improves Care: A Sub-study of the PROACTIVE-HF Clinical Trial

Presenter: Jason Guichard

March 21, 2023

Presentation THT 2023

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: Updated Results of the REBALANCE-HF Trial Roll-in Cohort

Presenter: Marat Fudim

March 21, 2023

Presentation THT 2023

Long-Term Improvement in Clinical Outcome in Patients With Combined Pre- and Post-Capillary Pulmonary Hypertension: 3-Year Analysis From PADN-5 Trial

Presenter: Dongming Hou

March 21, 2023

Presentation THT 2023

Left Ventricular Ejection Fraction and Intensive Up-Titration of Oral Treatment in Patients Recently Hospitalized for Heart Failure: Insights From the STRONG-HF Trial

Presenter: Matteo Pagnesi

March 21, 2023

News Conference News THT 2023

Higher Gradient After Tricuspid TEER Not Harmful at 1 Year: TriValve Registry

Caitlin E. Cox

March 21, 2023

Presentation THT 2023

Pulmonary Denervation Treatment of Pulmonary Hypertension Group II Study (TROPHY-II) Trial

Presenter: Greg Lewis

March 21, 2023

Advertisement

The TMVR Landscape: Second Generation Devices and Clinical Trial Pathways

Reducing Congestion by Removing Fluid From the Interstitium

Early Experience With Devices That Reduce Kidney Vascular Afterload From the Veins

Early Experience With Devices That Increase Kidney Perfusion From the Aorta

BrioHealth Solutions: Pump and Clinical Trial Design

Biomarkers of Congestion: Utility in Clinical Practice and Clinical Trials

Mechanisms of Diuretic Resistance

Contemporary Pharmacological Therapies for Acute Heart Failure

The Promise of AI for Improving Health Equity in Heart Failure

More Early Insights Into Interatrial Shunts in HF, but Little to Focus the Field

High-Intensity Care After Acute HF Pays Off Across LVEF Spectrum: STRONG-HF

REDUCE LAP-HF II Subanalysis Makes the Case for Invasive Exercise Tests

TMVR Clinical Trials: Ready for Prime Time or Stuck in the Mud?

Pulmonary Artery Denervation Makes Inroads in PAH Due to Left-Sided HF

Engaging Patients and Clinicians With Remote Pulmonary Artery Pressures Improves Care: A Sub-study of the PROACTIVE-HF Clinical Trial

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: Updated Results of the REBALANCE-HF Trial Roll-in Cohort

Long-Term Improvement in Clinical Outcome in Patients With Combined Pre- and Post-Capillary Pulmonary Hypertension: 3-Year Analysis From PADN-5 Trial

Left Ventricular Ejection Fraction and Intensive Up-Titration of Oral Treatment in Patients Recently Hospitalized for Heart Failure: Insights From the STRONG-HF Trial

Higher Gradient After Tricuspid TEER Not Harmful at 1 Year: TriValve Registry

Pulmonary Denervation Treatment of Pulmonary Hypertension Group II Study (TROPHY-II) Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content